
Figure 1
Model of Care.
Table 1
Top twenty diagnoses upon presentation at ED [ICD10V6].
| N | % | |
|---|---|---|
| Other and unspecified abdominal pain | 218 | 10.1% |
| Chest pain, unspecified | 105 | 4.8% |
| Other drugs, medicaments and biological substances | 67 | 3.1% |
| Suicidal ideation | 57 | 2.6% |
| Mental disorder, not otherwise specified | 57 | 2.6% |
| Unspecified personality and behaviour disorder | 54 | 2.5% |
| Chronic obstructive pulmonary disease, unspecified | 53 | 2.4% |
| Unknown and unspecified causes of morbidity | 50 | 2.3% |
| Dyspnoea | 50 | 2.3% |
| Asthma, unspecified | 37 | 1.7% |
| Malaise and fatigue | 36 | 1.7% |
| Nausea and vomiting | 35 | 1.6% |
| Elevated blood glucose level | 30 | 1.4% |
| Hypoglycaemia, unspecified | 30 | 1.4% |
| Procedure not carried out, unspecified reason | 29 | 1.3% |
| Unspecified dorsalgia, site unspecified | 27 | 1.2% |
| Mental and behavioural disorders due to alcohol | 26 | 1.2% |
| Other and unspecified convulsions | 23 | 1.1% |
| Anxiety disorder, unspecified | 22 | 1.0% |
| Headache | 22 | 1.0% |
Table 2
Most frequently identified patient needs at assessment.
| N | % | |
|---|---|---|
| Mental health | 43 | 40.6 |
| Pain management | 26 | 24.5 |
| Accommodation [Inc. homelessness] | 24 | 22.6 |
| D&A issues | 22 | 20.8 |
| Financial | 22 | 20.8 |
| Social isolation | 21 | 19.8 |
| Diabetes | 15 | 14.2 |
| Dietitian review | 14 | 13.2 |
| GP | 12 | 11.3 |
| Women’s health | 12 | 11.3 |

Figure 2
The Patient Journey.

Figure 3
Trend in ED Presentations of the Checkpoint Cohort. A. The average ED presentations of the Checkpoint cohort with a post enrolment period of at least 18 months [N = 51]. For patients with 18-24 month post enrolment period, pro rata adjustments are made to the 2nd yr Post ED presentation counts. B. The average year-on-year difference in ED presentations for the same Checkpoint Cohort (A). Solid (black) bars denote 95% CI. Dashed (green) bars are adjusted to indicate statistical difference (p-value .05) for paired comparisons [18].

Figure 4
Trend in ED Presentations of the Checkpoint Cohort for persistent frequent presenters. A. The average ED presentations of the Checkpoint cohort with a post enrolment period of at least 18 months [N = 15]. Persistent frequent presenters are defined as having ≥ 7 ED presentations each year for the last four years. For patients with 18–24 month post enrolment period, pro rata adjustments are made to the 2nd yr Post ED presentation counts. B. The average year-on-year difference in ED presentations for the same persistent frequent presenters cohort (A). Solid (black) bars denote 95% CI. Dashed (green) bars are adjusted to indicate statistical difference (p-value .05) for paired comparisons [18].

Figure 5
Trend in ED Presentations of the Checkpoint Cohort for non-persistent frequent presenters. A. The average ED presentations of the Checkpoint cohort with a post enrolment period of at least 18 months [N = 36]. Non-persistent frequent presenters are defined as not having ≥7 ED presentations each year for the last four years. For patients with 18-24 month post enrolment period, pro rata adjustments are made to the 2nd yr Post ED presentation counts. B. The average year-on-year difference in ED presentations for the same non-persistent frequent presenters cohort (A). Solid (black) bars denote 95% CI. Dashed (green) bars are adjusted to indicate statistical difference (p-value .05) for paired comparisons [18].
